[Clinical assessment of Cardilan].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy*; D005260:Female; D005632:Fructose / Q000627:therapeutic use*; D006801:Humans; D007408:Intestinal Absorption; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D011928:Raynaud Disease / Q000188:drug therapy; D013997:Time Factors
D009539:Nicotinic Acids; D005632:Fructose
Ocena kliniczna preparatu Kardylan.